ODYY (Odyssey Health) ROE % Adjusted to Book Value: Negative Equity% (As of Apr. 2026)


What is Odyssey Health ROE % Adjusted to Book Value?

Odyssey Health ODYY -3.33% ROE % Adjusted to Book Value is Negative Equity% as of Apr. 2026. The stock has 4 warning signs investors should review.

Odyssey Health's ROE % for the quarter that ended in Apr. 2026 was Negative Equity. Odyssey Health's PB Ratio for the quarter that ended in Apr. 2026 was N/A. Odyssey Health's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 was Negative Equity.

Odyssey Health ROE % Adjusted to Book Value Related Terms

Odyssey Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Odyssey Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Health ROE % Adjusted to Book Value Chart

Odyssey Health Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Odyssey Health Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 Negative Equity

ODYY vs PFSA, ESMC, NUWE: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Odyssey Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Odyssey Health ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Odyssey Health's ROE % Adjusted to Book Value falls into.


Odyssey Health ROE % Adjusted to Book Value Calculation

Odyssey Health's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Odyssey Health's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of Negative Equity% mean?
Odyssey Health (ODYY) has a ROE % Adjusted to Book Value of Negative Equity% as of Apr. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Odyssey Health and its competitors.
Is Odyssey Health's ROE % Adjusted to Book Value too high?
Odyssey Health's current ROE % Adjusted to Book Value is Negative Equity%.
How does Odyssey Health's ROE % Adjusted to Book Value compare to PFSA and ESMC?
Odyssey Health's ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Odyssey Health and its competitors. Odyssey Health's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current ROE % Adjusted to Book Value of Negative Equity%. The current ROE % Adjusted to Book Value is Negative Equity%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Odyssey Health (ODYY), the current ROE % Adjusted to Book Value is Negative Equity% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Health Business Description

Address 2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.